SCHEMBL24352409

SCHEMBL24352409

CNCc1ccccc1-c1nccnn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.44
▸ CASP6 P55212 2/20 0.42
▸ CYP1A2 P05177 10/20 0.40
▸ CYP2D6 P10635 9/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CYP3A4 P08684 7/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 4/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ MCL1 Q07820 1/20 0.35
▸ SLC6A2 P23975 3/20 0.34
▸ SLC6A4 P31645 3/20 0.34
▸ SLC6A3 Q01959 3/20 0.34
▸ PKM P14618 1/20 0.34
▸ CD274 Q9NZQ7 1/20 0.33
▸ SOS1 Q07889 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24312596 0.84 LTA4H (0.50) LTA4HCASP6CYP1A2CYP2D6MAPT
SCHEMBL24352277 0.75 LTA4H (0.45) LTA4HCASP6CYP1A2CYP2D6MAPT
SCHEMBL24352628 0.75 CYP1A2 (0.48) LTA4HCYP1A2CYP2D6MAPTCYP3A4
SCHEMBL28133533 0.72 CYP1A2 (0.50) CASP6CYP1A2CYP2D6CYP3A4ALDH1A1
SCHEMBL24352624 0.72 CYP1A2 (0.47) LTA4HCYP1A2CYP2D6MAPTCYP3A4
SCHEMBL22910530 0.71 LTA4H (0.47) LTA4HCASP6CYP1A2MAPTALDH1A1
SCHEMBL22910534 0.69 LTA4H (0.53) LTA4HSLC6A2SLC6A4SLC6A3CD274
SCHEMBL20657047 0.68 SMN1; SMN2 (0.46) CASP6MAPTALDH1A1HPGDTSHR
SCHEMBL404300 0.68 PBRM1 (0.47) CASP6MAPTALDH1A1KDM4EHPGD
SCHEMBL403090 0.68 LDHA (0.47) CYP1A2CYP2D6CYP3A4ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119395-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119395-A1 BICYCLIC COMPOUNDS SLC10A1, PKD1, CYP11B2 LTA4H 3035/4885CASP6 2981/4885CYP1A2 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback